Quality of Life Related to Functional Disability in Migraine Patients: A Systematic Review and Network Meta-analysis

Discussion: For short-term prevention of migraine, fremanezumab demonstrated slightly better improvement in disability compared with other anti-calcitonin gene-related peptide monoclonal antibodies in adult patients with migraine.
Source: The Clinical Journal of Pain - Category: Anesthesiology Tags: Review Articles Source Type: research